Skip to content
Open access

Distillation enables scalable high-fidelity virtual screening across ultra-large chemical libraries

Jul 2026 · bioRxiv · 0 citations · 37 references
Biology Medicine

TL;DR

Distillation is established as a practical strategy for scalable, high-fidelity virtual screening of ultra-large chemical libraries by transferring the predictive power of the structure-based model Boltz-2 into an efficient sequence-based surrogate, FastBindRank.

Abstract

Accurate virtual screening of ultra-large chemical libraries remains challenging. Existing approaches rely on lower-fidelity scoring functions or sampling-based strategies that can limit predictive accuracy and bias the exploration of chemical space. Here, we present FastBindRank, a distillation-based framework that transfers the predictive power of the structure-based model Boltz-2 into an efficient sequence-based surrogate. Trained on ∼1% of the 122-million-compound PubChem library, FastBindRank enables high-fidelity screening at scale. Applied to histone deacetylase 11 (HDAC11), FastBindRank substantially enriched high-confidence binders relative to the background chemical space. The lightweight model captured structural patterns associated with predicted binding, revealing structural determinants of binding. Under a comparable computational budget, FastBindRank achieved a 74-fold increase in hit rate and over a 30-fold increase in discovery yield over direct subset-based screening. Experimental validation confirmed the activity of two novel compounds. These results establish distillation as a practical strategy for scalable, high-fidelity virtual screening of ultra-large chemical libraries.

Read PDF

Similar papers

Jul 2026

Abstract A024: FastBindRank, a novel, scalable method for high-fidelity virtual screening of ultra-large chemical libraries idendtifies novel HDAC11 inhibitors

FastBindRank is presented, a distillation-based framework that transfers the predictive power of a high-accuracy structure-based model (Boltz-2) into a computationally efficient sequence-based surrogate and can identify functionally active novel compounds from ultra-large virtual screening.

J. Dai, Yueyue Wang, N. Shan et al. · 0 citations
Review Open access Jul 2026

BoltzMol-1: Towards Reliable Virtual Screening for Fast and Cost-Effective Hit Discovery

This work establishes a practical framework for low-throughput, cost-constrained discovery campaigns capable of delivering chemically tractable binders with favorable property profiles, and introduces a suite of ADMET models for kinetic solubility, lipophilicity, and Caco-2 permeability to improve developability at the...

Noah Getz, Geoffrey Smith, Avene Colgan et al. · 0 citations
Jul 2026

Real-World Assessment of Machine-Learned Docking Using Bioassay-Derived Benchmarks

This work systematically evaluates the performance of a popular ML-based docking method, DiffDock-Pocket, on high-throughput screening (HTS) data sets derived from the PubChem BioAssay database, a premier source of bioactivity data.

Furyal Ahmed, M. Soellner, Charles L. Brooks · 0 citations
Aug 2026

Evaluating BioEmu-Generated Kinase Ensembles Reveals Structure Selection as the Virtual Screening Bottleneck.

It is shown that prospective structure selection, rather than structure generation, represents the primary bottleneck in ensemble-based VS, highlighting an urgent need for novel structural descriptors to identify high-performing conformations.

Jaeoh Shin, K. Joo, Jejoong Yoo · 1 citation
Preprint Aug 2026

PETA:Parameter-Efficient Test-Time Adaptation for Virtual Screening

This work forms the specialization of pretrained virtual screening models to individual pockets as a test-time adaptation problem and proposes PETA, a parameter-efficient framework that directly adapts pretrained model at test time and outperforms both pretrained and fully retrained baselines while updating only the La...

Jia-Qi Lin, Ying-Hua Yao, Chang-Ran Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.